BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 33556477)

  • 1. Mechanism of gypenosides of Gynostemma pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT/mTOR pathway.
    Liu H; Li X; Duan Y; Xie JB; Piao XL
    J Ethnopharmacol; 2021 May; 271():113907. PubMed ID: 33556477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gypenoside-Induced Apoptosis via the PI3K/AKT/mTOR Signaling Pathway in Bladder Cancer.
    Li X; Liu H; Lv C; Du J; Lian F; Zhang S; Wang Z; Zeng Y
    Biomed Res Int; 2022; 2022():9304552. PubMed ID: 35402614
    [No Abstract]   [Full Text] [Related]  

  • 3. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of Gynostemma pentaphyllum in treatment of metabolism associated fatty liver disease based on network pharmacology and molecular docking].
    Li SD; Li SL; Liu JK; Wang Z; Yuan PP
    Zhongguo Zhong Yao Za Zhi; 2021 Oct; 46(19):5080-5087. PubMed ID: 34738404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Root extract of Hemsleya amabilis Diels suppresses renal cell carcinoma cell growth through inducing apoptosis and G
    Li K; You G; Jiang K; Wang R; Li W; Meng Y; Fang Y; Chen W; Zhu G; Song J; Wang W; Su H; Hu B; Sun F; Jia Z; Li C; Zhu J
    J Ethnopharmacol; 2024 Jan; 318(Pt B):117014. PubMed ID: 37557938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network pharmacology approach and experimental validation to investigate the anticancer mechanism and potential active targets of ethanol extract of Wei-Tong-Xin against colorectal cancer through induction of apoptosis via PI3K/AKT signaling pathway.
    Lin F; Zhang G; Yang X; Wang M; Wang R; Wan M; Wang J; Wu B; Yan T; Jia Y
    J Ethnopharmacol; 2023 Mar; 303():115933. PubMed ID: 36403742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new discovery: Total Bupleurum saponin extracts can inhibit the proliferation and induce apoptosis of colon cancer cells by regulating the PI3K/Akt/mTOR pathway.
    Zhang X; Liu Z; Chen S; Li H; Dong L; Fu X
    J Ethnopharmacol; 2022 Jan; 283():114742. PubMed ID: 34655668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of heat-processed Gynostemma pentaphyllum on high-fat diet-fed mice of obesity and functional analysis on network pharmacology and molecular docking strategy.
    Xie P; Guo M; Xie JB; Xiao MY; Qi YS; Duan Y; Li FF; Piao XL
    J Ethnopharmacol; 2022 Aug; 294():115335. PubMed ID: 35513215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of autophagy enhances apoptosis induced by the PI3K/AKT/mTor inhibitor NVP-BEZ235 in renal cell carcinoma cells.
    Li H; Jin X; Zhang Z; Xing Y; Kong X
    Cell Biochem Funct; 2013 Jul; 31(5):427-33. PubMed ID: 23086777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network pharmacology and experimental verification of the potential mechanism of Er-Xian decoction in aplastic anemia.
    Ye M; Liu G; Yang Y; Yang H; Ren J; Chen W; Gao Z
    Sci Rep; 2023 Oct; 13(1):17385. PubMed ID: 37833363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Network pharmacology-based strategy to investigate pharmacological mechanisms of Tinospora sinensis for treatment of Alzheimer's disease.
    Zhou F; He K; Guan Y; Yang X; Chen Y; Sun M; Qiu X; Yan F; Huang H; Yao L; Liu B; Huang L
    J Ethnopharmacol; 2020 Sep; 259():112940. PubMed ID: 32389853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-Elemene induces apoptosis in human renal-cell carcinoma 786-0 cells through inhibition of MAPK/ERK and PI3K/Akt/ mTOR signalling pathways.
    Zhan YH; Liu J; Qu XJ; Hou KZ; Wang KF; Liu YP; Wu B
    Asian Pac J Cancer Prev; 2012; 13(6):2739-44. PubMed ID: 22938451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3K-Akt-mTOR inhibition by GNE-477 inhibits renal cell carcinoma cell growth
    Ye X; Ruan JW; Huang H; Huang WP; Zhang Y; Zhang F
    Aging (Albany NY); 2020 May; 12(10):9489-9499. PubMed ID: 32421688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology-based prediction and validation of the active ingredients and potential mechanisms of the Huangxiong formula for treating ischemic stroke.
    Zhao S; Zhang P; Yan Y; Xu W; Li J; Wang L; Wang N; Huang Y
    J Ethnopharmacol; 2023 Aug; 312():116507. PubMed ID: 37080367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research on the Potential Mechanism of Gypenosides on Treating Thyroid-Associated Ophthalmopathy Based on Network Pharmacology.
    Li K; Li H; Xu W; Liu W; Du Y; He JF; Ma C
    Med Sci Monit; 2019 Jul; 25():4923-4932. PubMed ID: 31268042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H; Zhu D; Zheng Z; Cai Y; Chen Z; Xie W
    Clin Transl Oncol; 2019 Jul; 21(7):939-949. PubMed ID: 30607788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network Analysis and Basic Experiments on the Inhibition of Renal Cancer Proliferation and Migration by Alpinetin through PI3K/AKT/ mTOR Pathway.
    Guo Y; Jiang L; Luo S; Hu D; Zhao X; Zhao G; Tang W
    Curr Mol Med; 2024; 24(1):134-144. PubMed ID: 37221689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uncovering the anti-NSCLC effects and mechanisms of gypenosides by metabolomics and network pharmacology analysis.
    Qi YS; Xie JB; Xie P; Duan Y; Ling YQ; Gu YL; Piao XL
    J Ethnopharmacol; 2021 Dec; 281():114506. PubMed ID: 34371113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.